BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18230899)

  • 21. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Fujimoto WY
    Am J Med; 2000 Apr; 108 Suppl 6a():9S-14S. PubMed ID: 10764845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The islet circadian clock: entrainment mechanisms, function and role in glucose homeostasis.
    Rakshit K; Qian J; Colwell CS; Matveyenko AV
    Diabetes Obes Metab; 2015 Sep; 17 Suppl 1(0 1):115-22. PubMed ID: 26332976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olfactomedin 4 Deletion Improves Male Mouse Glucose Intolerance and Insulin Resistance Induced by a High-Fat Diet.
    Liu W; Aerbajinai W; Li H; Liu Y; Gavrilova O; Jain S; Rodgers GP
    Endocrinology; 2018 Sep; 159(9):3235-3244. PubMed ID: 30052841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and type 2 diabetes: slow down!--Can metabolic deceleration protect the islet beta cell from excess nutrient-induced damage?
    Andrikopoulos S
    Mol Cell Endocrinol; 2010 Mar; 316(2):140-6. PubMed ID: 19815054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity-induced diabetes in mouse strains treated with gold thioglucose: a novel animal model for studying β-cell dysfunction.
    Karasawa H; Takaishi K; Kumagae Y
    Obesity (Silver Spring); 2011 Mar; 19(3):514-21. PubMed ID: 20706204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In beta-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion.
    Maechler P; Carobbio S; Rubi B
    Int J Biochem Cell Biol; 2006; 38(5-6):696-709. PubMed ID: 16443386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comeback for the beta cells in the pathogenesis of diabetes].
    Mulder H
    Lakartidningen; 2010 Nov 10-16; 107(45):2796-800. PubMed ID: 21179864
    [No Abstract]   [Full Text] [Related]  

  • 29. Link between obesity and type 2 diabetes.
    Golay A; Ybarra J
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):649-63. PubMed ID: 16311223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes mellitus: a disease of the governance of the glucose-insulin system: an experimental metabolic control analysis study.
    Trombetta M; Boselli L; Cretti A; Calì A; Vettore M; Caruso B; Dorizzi R; Avogaro A; Muggeo M; Bonora E; Bonadonna RC
    Nutr Metab Cardiovasc Dis; 2013 Jan; 23(1):23-30. PubMed ID: 21937205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.
    Walker M; Mari A; Jayapaul MK; Bennett SM; Ferrannini E
    Diabetologia; 2005 Dec; 48(12):2470-6. PubMed ID: 16261308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-cell failure as a complication of diabetes.
    Chang-Chen KJ; Mullur R; Bernal-Mizrachi E
    Rev Endocr Metab Disord; 2008 Dec; 9(4):329-43. PubMed ID: 18777097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus.
    Maassen JA; Romijn JA; Heine RJ
    Diabetologia; 2007 Oct; 50(10):2036-41. PubMed ID: 17712547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic glucose metabolism and insulin resistance in NIDDM and obesity.
    Barrett EJ; Liu Z
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):875-901. PubMed ID: 8304916
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of beta-cell function of pancreatic islets isolated from bank voles developing glucose intolerance/diabetes: an animal model showing features of both type 1 and type 2 diabetes mellitus, and a possible role of the Ljungan virus.
    Blixt M; Niklasson B; Sandler S
    Gen Comp Endocrinol; 2007; 154(1-3):41-7. PubMed ID: 17686482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].
    Yoshimoto K; Ozawa S; Ishida H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():95-9. PubMed ID: 15779352
    [No Abstract]   [Full Text] [Related]  

  • 37. The mechanisms linking adiposopathy to type 2 diabetes.
    Yang J; Kang J; Guan Y
    Front Med; 2013 Dec; 7(4):433-44. PubMed ID: 24085616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes.
    Irles E; Ñeco P; Lluesma M; Villar-Pazos S; Santos-Silva JC; Vettorazzi JF; Alonso-Magdalena P; Carneiro EM; Boschero AC; Nadal Á; Quesada I
    Mol Cell Endocrinol; 2015 Mar; 404():46-55. PubMed ID: 25633666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic signaling in fuel-induced insulin secretion.
    Prentki M; Matschinsky FM; Madiraju SR
    Cell Metab; 2013 Aug; 18(2):162-85. PubMed ID: 23791483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.